Bicycle Therapeutics plc (BCYC)
NASDAQ: BCYC · Real-Time Price · USD
4.930
-0.360 (-6.81%)
Apr 21, 2026, 4:00 PM EDT - Market closed
Bicycle Therapeutics Employees
Bicycle Therapeutics had 288 employees as of December 31, 2025. The number of employees decreased by 17 or -5.57% compared to the previous year.
Employees
288
Change (1Y)
-17
Growth (1Y)
-5.57%
Revenue / Employee
$252,035
Profits / Employee
-$760,278
Market Cap
343.66M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 288 | -17 | -5.57% |
| Dec 31, 2024 | 305 | 21 | 7.39% |
| Dec 31, 2023 | 284 | 48 | 20.34% |
| Dec 31, 2022 | 236 | 117 | 98.32% |
| Dec 31, 2021 | 119 | 32 | 36.78% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Puma Biotechnology | 179 |
| Cabaletta Bio | 156 |
| Nautilus Biotechnology | 130 |
| Prelude Therapeutics | 79 |
| Rezolute | 75 |
| Immuneering | 53 |
| Surrozen | 44 |
| DiaMedica Therapeutics | 35 |
BCYC News
- 21 hours ago - Bicycle Therapeutics Announces Oral and Poster Presentations at the 2026 ASCO Annual Meeting - Business Wire
- 2 days ago - Bicycle Therapeutics Provides Update on Nuzefatide Pevedotin and EphA2 Pipeline at the AACR Annual Meeting 2026 - Business Wire
- 5 weeks ago - Bicycle Therapeutics Announces Oral and Poster Presentations at the AACR Annual Meeting 2026 - Business Wire
- 5 weeks ago - Bicycle Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2025 Financial Results - Business Wire
- 2 months ago - Bicycle Therapeutics Announces Leadership Transitions for Next Phase of Innovation Across Oncology Pipeline - Business Wire
- 3 months ago - Bicycle Therapeutics Highlights 2025 Accomplishments and Strategic Priorities for 2026 - Business Wire
- 4 months ago - Bicycle Therapeutics Establishes Multiple Strategic Partnerships to Create End-to-End Supply Chain to Support its Wholly Owned Radiopharmaceutical Pipeline - Business Wire
- 5 months ago - Bicycle Therapeutics to Participate in the Jefferies London Healthcare Conference - Business Wire